February 28, 2015 10:25 PM ET


Company Overview of AVANT Immunotherapeutics Inc.

Company Overview

As of March 7, 2008, AVANT Immunotherapeutics Inc. was acquired by Celldex Therapeutics Inc. in a reverse merger transaction. AVANT Immunotherapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of vaccines that harness the human immune response system for the prevention and treatment of diseases. It develops various vaccines and immunotherapeutics addressing a range of applications, including bacterial and viral diseases, biodefense, food safety, and cardiovascular diseases. The company offers Rotarix for the treatment of rotavirus infection; Ty800 typhoid fever vaccine; and MeganVac 1 and MeganEgg vaccines for use in chickens for protect...

119 Fourth Avenue

Needham, MA 02494-2725

United States

Founded in 1983





Key Executives for AVANT Immunotherapeutics Inc.

AVANT Immunotherapeutics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
EpicentRx, Inc. United States
Artecel Sciences United States
Spectral Image, Inc. United States
TimTec, Inc. United States
Akceli Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVANT Immunotherapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.